Form 4: CytomX Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Alejandra Carvajal, Chief Legal Officer of CytomX Therapeutics, Inc., reported multiple transactions in common stock on August 3, 2026.
Summary
- Grant/award: acquired 100,000 Common Stock on August 3, 2026; holds 100,000 after (Direct).
- Grant/award: acquired 450,000 Stock Option (Right to Buy) on August 3, 2026; holds 450,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Alejandra Carvajal — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Grant/award | Common Stock | 100,000 | — | — | 100,000 |
| 2026-08-03 | Grant/award | Stock Option (Right to Buy) | 450,000 | — | — | 450,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Grant/award (100,000 shares) |
| 2026-08-03 | Grant/award (450,000 shares) |
Keywords
insider transaction, Form 4, CTMX, CytomX Therapeutics, Inc., neutral, Alejandra Carvajal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.